More information: Marc Fornt‐Suñé et al, Protein Nanoparticles for Targeted SARS‐CoV‐2 Trapping and Neutralization, Advanced ...

SARS-CoV-2 is a case in point ... Part of the delivery problem was solved by use of lipid nanoparticle packaging. The other breakthrough was the discovery that substituted nucleosides incorporated ...

One promising approach relies on the use of nanoparticles, with several metal and metal oxide nanoparticles showing anti-viral activity against SARS-CoV-2, the virus that causes COVID-19. With this in ...

In addition to SARS-CoV-2, the virus that causes COVID-19 ... versions of sarbecovirus receptor-binding proteins (RBDs) to nanoparticles, the researchers created a vaccine that generates ...

The first was that the SARS-CoV-2 virus evolves over time, rendering available vaccines less effective ... 5 In a recent publication in Cell, Hoffmann describes the novel technique he developed that ...

3 In addition to mRNA vaccines, potent antibody responses can also be elicited by protein-based vaccines, such as the Novavax NVX-CoV2373 vaccine, that present the SARS-CoV-2 spike protein on the ...

Five years later, we can tell the tale of using the tools of science, we were able to turn the tide on SARS-CoV ... 9,10 2. Light scattering solutions for vaccine-related molecules and ...

Once the researchers produced the RBD-nanoparticles, they evaluated each one in mice. After each mouse received three doses of one of the vaccines, the researchers analyzed how well the resulting ...

In the graphics that follow, Scientific American presents detailed explanations, current as of mid-June, into how SARS-CoV-2 sneaks inside human cells, makes copies of itself and bursts out to ...

Conference call begins at 4:30 p.m. Eastern time todayMIAMI, Feb. 27, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and 12 ...